IH vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

IH

44.8
AI Score
VS
UTI Wins

UTI

45.4
AI Score

Investment Advisor Scores

IH

45score
Recommendation
HOLD

UTI

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IH UTI Winner
Revenue 115.40M 835.62M UTI
Net Income 13.64M 63.02M UTI
Net Margin 11.8% 7.5% IH
Operating Income 9.55M 83.47M UTI
ROE 9.6% 19.2% UTI
ROA 7.0% 7.6% UTI
Total Assets 195.67M 826.14M UTI
Cash 164.61M 127.36M IH
Current Ratio 3.57 1.07 IH

Relative Price Performance (Last 90 Days)

IH 1M: +3.5% · 3M: -16.3% UTI 1M: -0.3% · 3M: -46.1%

Current Technical Phase

IH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.5 · Price: $1.18

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $20.37

Fundamentals Snapshot

Metric IH UTI
Market Cap — —
Forward P/E 58.8 28.3
Trailing P/E 19.2 33.8
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.7% 0.6%
Operating Margin -0.1% 0.0%
EPS 0.06 0.61
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.